Rybelsus fda approval date?

When was Rybelsus approved by the FDA?

Rybelsus (semaglutide) received FDA approval for oral use on September 20, 2019. [1]

Was that approval for the same indication as injections (Ozempic)?

Rybelsus’s initial FDA approval was for type 2 diabetes treatment (as an oral formulation of semaglutide), distinct from Ozempic (semaglutide injection), though both are GLP-1–based therapies. [1]

Why might you see different dates online (label updates vs. first approval)?

Search results sometimes show later dates because of labeling updates, supplemental approvals, or changes tied to new doses/indications. The FDA “approval date” most people mean is the first time the drug was approved, which for Rybelsus is September 20, 2019. [1]

Sources:
[1] https://www.drugs.com/history/rybelsus.html